CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: Evolut PRO China Clinical Study [NA]
Summary
The Evolut PRO China trial for severe symptomatic aortic stenosis is active but not recruiting, with results posted on 2024-11-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medtronic Cardiovascular | Conditions: Severe, Symptomatic Aortic Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-29